Summary Recent studies have shown that bafilomycin A,-sensitive vacuolar-type H'-ATPase (V-ATPase) plays important roles in cell growth and differentiation. However, there is no published study that has focused on the expression of V-ATPase in human tumour tissues. This study was designed to examine the mRNA and protein levels for the 16 kilodalton (kDa) proteolipid of V-ATPase in human pancreatic carcinoma tissues. We first investigated the mRNA level for V-ATPase in six cases of invasive pancreatic cancers and two normal pancreases, using reverse transciption-polymerase chain reaction technique. Then, we examined immunohistochemically the level of V-ATPase protein in 49 pancreatic cancers and ten benign cystic neoplasms of the pancreas, using antisera raised against the 16 kDa proteolipid. There was a notable difference in the level of V-ATPase mRNA between normal and pancreatic carcinoma tissues, with no evident difference in the expression of the f-actin gene. Immunohistochemically, 42 out of 46 invasive ductal cancers (92%) displayed a mild to marked immunoreactivity for V-ATPase in the cytoplasm, whereas neither non-invasive ductal cancers nor benign cystic neoplasms expressed detectable immunoreactive proteins. These findings suggest that the overexpression of V-ATPase protein is characteristic of invasive pancreatic tumours. V-ATPase may play some crucial roles in tumour progression.
Recent studies have suggested that vacuolar type H+-ATPase (V-ATPase), which has a molecular structure and drug sensitivities distinct from mitochondrial F,F,-type ATPase (F-ATPase) and gastric (H+ K+)-ATPase (P-ATPase), is responsible for the acidification of intracellular compartments in eukaryotic cells. This acidification is crucial for a variety of cellular processes including receptor-mediated endocytosis, intracellular membrane traffic, macromolecular processing and degradation and coupled transport in vacuolar compartments (Forgac, 1989; Nelson, 1991; Forgac, 1992) . V-ATPase has been purified from endomembrane systems including lysosomes, chromaffin granules, endosomes, synaptic vesicles and clathrin-coated vesicles (Mellman et al., 1986; Arai et al., 1987a; Nelson, 1989; Moriyama and Nelson, 1989; Futai, 1990, Arai et al., 1993) . In addition, V-ATPase also has been detected in the plasma membrane of a few specalised cell types including osteoclasts (Baron et al., 1985; Akisaka and Gay, 1986; Vaananen et al., 1990) , macrophages (Swallow et al., 1990; Bidani and Brown, 1992; Tapper and Sundler, 1992) , activated neutrophils (Nanda et al., 1992) , renal intercalated cells (Verlander et al., 1991) and some tumour cell lines (Martinez-Zaguilan et al., 1991) .
V-ATPase is composed of two cytosolic (V1) and transmembrane (VO) domains (Bowman et al., 1989; Moriyama et al., 1992) . The V1 domain is composed of a hexamer of three subunit A proteins (65-75 kDa) and three subunit B proteins (55-60 kDa) plus accessory subunits C, D and E, which altogether form an approximately 500 kDa complex with the structure A3B3CIDIE1 (Arai et al., 1988; Adachi et al., 1990) . The V1 domain, although not active as an ATPase, contains both the catalytic and non-catalytic nucleotide binding sites located on the A and B subunits respectively (Manolson et al., 1985; Feng and Forgac, 1992) . The role of accessory subunits C, D and E in V-ATPase function is not fully understood, although a combination of purified subunits A, B, C and E promotes the ATPase activity of the V1 subcomplex in vitro and strong evidence suggests that the V1 subcomplex is actually involved in the formation of functional H+-ATPase through attachment to the membrane-embedded V0 domain (Xie and Stone, 1988; Puopolo and Forgac, 1990 Zhang et al., 1992) . Among these subunits, the 16 kDa subunit (proteolipid) is considered to be an essential component of the membrane sector which is responsible for conducting protons across membranes (Arai et al., 1987b; Sun et al., 1987; Kaestner et al., 1988) . Bafilomycin A1, a 16-membered macrolide antibiotic isolated from Streptomyces griseus, has been identified as a potent selective inhibitor of V-ATPases, causing complete inhibition in vitro at nanomolar concentrations (Bowman et al., 1988) . It has been demonstrated that bafilomycin A, can inhibit the growth of a variety of cultured cells in a dosedependent manner (Nelson and Nelson, 1990; Ohkuma et al., 1993; Manabe et al., 1993) . The results suggested that the pH maintenance of acidic compartment driven by V-ATPase is necessary for cell proliferation and its perturbation by bafilomycin A1 results in the suppression of cell proliferation. However, the precise mechanisms by which bafilomycin Al suppresses the proliferation of various cultured cells when added to the culture medium have not yet been clarified . Furthermore, to our knowledge, there is no published study that has focused on the expression of V-ATPases in human tumour tissues.
In this study, we first picked up the 16 kDa subunit of human V-ATPase which is one of the best documented and most critical subunits of V-ATPases (Arai et al., 1987b; Sun et al., 1987) , and examined the mRNA and protein levels for the 16 kDa subunit in human pancreatic carcinoma tissues by light microscopic immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) technique. We used human pancreatic carcinoma tissues in this study for the following reasons: (1) Lemoine et al., 1993; Yamanaka et al, 1993; Leung et al., 1994) ; (2) these growth factors and their receptors are considered to be internalised by endocytosis and pass through endosomal and lysosomal compartments of decreased pH (Forgac, 1989; Nelson, 1991; Forgac, 1992) ; and (3) among these growth factors, basic fibroblast growth factor is considered to enter the nucleus through acidic vesicles before it promotes cell growth (Bouche et al., 1987 Anti-16 kDa subunit antisera The anti-16 kDa subunit antisera specific for the N-terminus of the rat liver 16 kDa V-ATPase protein has recently been obtained (Finbow et al., 1993) . These antisera were raised in rabbits by injecting the synthetic peptide, NH2-Asn-Pro-GluTyr-Ser-Ser-Phe-Phe-Cys-COOH which was coupled with keyhole limpet haemocyanin (KLH; Sigma) by maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) method according to the established procedure (Harlow and Lane, 1988) . In this study, we used these antisera instead of the antisera against human 16 kDa V-ATPase protein for the following reasons: (1) the synthetic peptide used in the present study is closely similar to the N-terminus of human 16 kDa subunit (Nezu et al., 1992) ; (2) the specificity of the primary antisera has already been characterised by Finbow et al. (1993) The amount of RNA is proportional to the amplified PCR products only during the exponential phase of DNA synthesis (Chelly et al., 1988) . Therefore, we first determined the exponential phase of DNA synthesis (Figure 1) . From this result, we used 25 cycles for V-ATPases and 18 cycles for fiactin as the best condition to determine the expression levels of these genes. We first investigated the relative amount ratio of RT-PCR products between the 16 kDA-subunit of human VATPase and f-actin in six selected cases of human pancreatic ductal cancers and two normal pancreases. Two normal pancreas samples were obtained from another source as described under 'Materials and methods' because it was extremely difficult to obtain total RNAs from the small amount of the non-cancerous normal pancreatic tissue sample. As shown in Figure 2, In all sections of normal pancreas samples, a marked VATPase immunoreactivity was observed in islet cells (Figure   4a ), whereas immunostaining was not observed in acinar or ductal cells. Therefore, we used the islet cells as positive internal controls in this study. In each immunostaining run, to test for the specificity of immunostaining, the primary antisera were replaced by non-immune normal mouse serum in the first reaction and a competitive inhibition test was also performed that resulted in no detectable staining.
The immunohistochemical staining and its quantification of V-ATPase protein in human pancreatic tumour specimens are shown in Figure 4b-d) and summarsed in Table II. A total of 42 out of 46 invasive tubular or papillary adenocarcinomas (92%) displayed mild to marked immunoreactivity to V-ATPase (Figure 4c and 4d) . The immunoreactive pattern was finely granular and was generally present diffusely in the cytosplasm of carcinoma cells. The intensity of V-ATPase immunoreactivity showed heterogeneity both between and within cases. Usually its immunoreactivity was more pronounced at the infiltrative margins of the tumours. In contrast, three intraductal (non-invasive) papillary adenocarcinomas did not express detectable V-ATPase immunoreactive proteins, whereas adjacent normal islet cells were stained intensely. In addition, all ten benign cystic neoplasms of the pancreas did not express V-ATPase immunoreactive proteins (Figure 4b ). In non-tumorous tissues, only the islet cells displayed a marked immunoreactivity for V-ATPase protein as well as in normal pancreatic tissues. The expression level of V-ATPase protein paralleled well with that of V-ATPase mRNA in six cases with human pancreatic ductal cancer that were subjected to RT-PCR analysis (Tables I and II (Kern et al., 1987; Ghadially, 1988 (Numata et al., 1995a,b) . Therefore, our present results may also be interpreted in the light of interactions between carcinoma cells and surrounding stromal or normal epithelial cells. Furthermore, the E5 oncoprotein of bovine papilloma virus type 1 has been shown to bind selectively to the 16 kDa subunit of V-ATPase and involves the ligand-independent activation of growth factor receptor (Goldstein et al., 1992) . These findings suggest that 16 kDa subunit of V-ATPase may play an important role in tumour transformation through a potential link between receptor signal transduction pathways and membrane pore activity. The 16 kDa subunit has also been shown to be expressed as a gap junction (Finbow et al., 1994) and mediatophore (Israel et al., 1986) . Therefore, we cannot exclude the possibility of some novel functions of the 16 kDa subunit in pancreatic cancers besides its known functions. In any case, precise intracellular localisation of 16 kDa subunit and other subunits is prerequisite for a better understanding of functional importance of V-ATPase.
